This CME Symposium takes place on Tuesday, October 15, 2024, from 12:15 - 1:15 PM PT during the 2024 Neurocritical Care Society (NCS) Annual Meeting at the Manchester Grand Hyatt in San Diego, California.
HAZLET, N.J. - Sept. 17, 2024 - PRLog -- In this symposium, an expert multidisciplinary faculty will provide insights into and interpretations of clinical data, and challenging cases will reinforce key elements of prudent management of major bleeding in patients taking DOACs and experiencing intracranial hemorrhage.
The educational objectives include:
- Interpret clinical evidence with a specific reversal agent targeting dabigatran
- Explain clinical trial data for a specific reversal agent for factor Xa inhibition
- Describe critical considerations in managing the patient experiencing intracranial hemorrhage while receiving a direct oral anticoagulant (DOAC)
Click here for more information
CHAIR
Truman J. Milling, Jr., MD
Professor, Department of Clinical Sciences
Tilman J. Fertitta Family College of Medicine
University of Houston, Houston, Texas
Associate Professor
Departments of Neurology and Surgery and Perioperative Care
Dell Medical School at the University of Texas Austin
Austin, Texas
FACULTY
Anne Alexandrov, PhD, AGACNP-BC, ANVP-BC, CCRN, FAAN
Professor of Nursing and Neurology
The University of Tennessee Health Science Center
Memphis, Tennessee
Paul Dobesh, PharmD
Professor
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska
Joshua Goldstein, MD, PhD
Professor of Emergency Medicine
Harvard Medical School
Endowed Chair in Emergency Medicine Research
Massachusetts General Hospital
Boston, Massachusetts
This educational activity is intended for clinicians managing patients experiencing intracranial hemorrhage.
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.0 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Photos: (Click photo to enlarge)
Source: CMEPlanet
Read Full Story - 2024 NCS CME Symposium - Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage | More news from this source
Press release distribution by PRLog
